Quick Summary:
In the continuously evolving global economy, staying ahead of market trends and innovative developments is paramount for senior-level executives. At the forefront of this challenge is the High Throughput Process Development industry, which is projected to experience significant growth in the coming years. A comprehensive understanding of this market, its segments, and key players can provide strategic advantages in decision-making and future planning.
Our latest market research report offers an in-depth analysis of this rapidly growing sector. The report's detailed breakdown of significant sub-sectors, such as Monoclonal Antibodies, provides valuable insights into projected growth trends. Furthermore, the report offers geographical analysis, highlighting potential global hotspots, including the U.S. and China, for High Throughput Process Development. Featured competitor analysis and online collaborative updates ensure you stay abreast of any relevant changes or developments. Ensure your organization stays ahead in the ever-evolving market landscape by investing in this comprehensive report.
Global High Throughput Process Development Market to Reach $24.6 Billion by 2030
The global market for High Throughput Process Development estimated at US$13.8 Billion in the year 2022, is projected to reach a revised size of US$24.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$17.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Molecule Types segment is readjusted to a revised 5.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 13.5% CAGR
The High Throughput Process Development market in the U.S. is estimated at US$3.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 13.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.Select Competitors (Total 33 Featured) -
- Agilent Technologies
- Aurora Biomed
- Axxam S.P.A.
- Bio-Rad Laboratories
- Danaher Corporation
- Eppendorf
- GE Healthcare
- Hamilton Company
- Merck Millipore
- Perkinelmer
- Sartorius Stedim Biotech
- Tecan Group
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for High Throughput Process Development?
What is the growth rate of the Global Market for High Throughput Process Development?
What is the forecasted size of the Global Market for High Throughput Process Development?
Who are the key companies in the Global Market for High Throughput Process Development?
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 13.8 Billion |
| Forecasted Market Value ( USD | $ 24.6 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Agilent Technologies
- Aurora Biomed
- Axxam S.P.A.
- Bio-Rad Laboratories
- Danaher Corporation
- Eppendorf
- GE Healthcare
- Hamilton Company
- Merck Millipore
- Perkinelmer
- Sartorius Stedim Biotech
- Tecan Group
- Thermo Fisher Scientific, Inc.
